Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db5634f42c00727c6be65e639b54fcc1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 |
filingDate |
2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adff66e2ebe68446da0a97ef3d1296c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a96d1aba1e18265897b8ae79e31c2ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bff3c00a0533fcc60eb737355ece123 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9943869f4de3c897200039a13acc0792 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6cceb54776a334d8bca9b25e112dad6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_280d2494f29a7827ec3fa2a9c2a7043b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a7548b35c59de7b6dda64e7f112211a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dff404fd420287547cf9e7d329ca2639 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74f5b7efd4e6c7a60775a55a49fe3e5c |
publicationDate |
2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2020127846-A9 |
titleOfInvention |
Condensed pyrroles as novel bromodomain inhibitors |
abstract |
Compounds of formula (1) or (2) and their use in the treatment of diseases or conditions for which a bromodomain inhibitor is indicated. |
priorityDate |
2018-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |